Intestinal metaplasia in portal hypertensive gastropathy: a frequent pathology

Duygu Ibrişim1, Uğur Cevikbaş, Filiz Akyüz

  • 1Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. duygu@ibrisim.net

Abstract

Insights

Intestinal metaplasia (IM) and atrophy are more frequent in patients with portal hypertensive gastropathy (PHG). PHG is a reliable indicator of these gastric mucosal changes.

Area of Science:

  • Gastroenterology
  • Pathology
  • Hepatology

Background:

  • Portal hypertensive gastropathy (PHG) is a common complication in patients with portal hypertension.
  • Intestinal metaplasia (IM) and gastric atrophy are significant histopathological findings with potential implications for gastric cancer risk.

Purpose of the Study:

  • To investigate the prevalence of intestinal metaplasia (IM) in patients diagnosed with portal hypertensive gastropathy (PHG).
  • To compare the frequency of IM in PHG patients against a control group with functional dyspepsia.
  • To assess the correlation between PHG severity and IM, as well as identify independent predictors for IM and atrophy.

Main Methods:

  • Prospective evaluation of 289 patients across three groups: controls (functional dyspepsia), cirrhotics, and non-cirrhotic portal hypertensives.
  • Histological examination of gastric mucosal biopsies (antrum, angulus, corpus) for atrophy, IM, dysplasia, Helicobacter pylori (Hp), and PHG.
  • Statistical analysis including comparison between groups and multivariate analysis to identify independent predictors.

Main Results:

  • Intestinal metaplasia (IM) was significantly more frequent in patients with PHG compared to controls (P<0.05) and correlated with PHG severity.
  • Gastric atrophy was also more prevalent in cirrhotic patients than in controls (P<0.05).
  • Helicobacter pylori (Hp) prevalence was higher in the control group and positively correlated with atrophy, while PHG and age were independent predictors for IM.

Conclusions:

  • Higher frequencies of gastric atrophy and IM are observed in patients with PHG.
  • PHG serves as a reliable indicator for the presence of IM and atrophy in the gastric mucosa.
  • These findings highlight the importance of evaluating gastric histology in patients with PHG.

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...